Feeding of partially hydrogenated fish oils to rats in comparison with partially hydrogenated soybean oil and refined rapeseed oil: a combined chronic oral toxicity and carcinogenicity study with in utero phase. 1988

I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
International Association of Fish Meal Manufacturers, Potters Bar, Herts, U.K.

Partially hydrogenated fish oils (PHFO) have been widely used in human food products for many years, particularly in Europe, North and South America and in South Africa. Animal studies, mainly with rapeseed oil, suggested that erucic acid might be responsible for morphological changes in the myocardium. It was suggested that other members of the docosenoic (22:1) family of fatty acids might produce similar effects to those ascribed to erucic acid. Certain PHFO can contain relatively high levels of these other isomers. Thus it was decided to evaluate PHFO of differing 22:1 levels in comparison with partially hydrogenated soybean oil (PHSBO) and refined rapeseed oil (LEAR) in a rat life span study, preceded by a breeding period in which the experimental lipids were fed to male and female parents. Two commercially produced PHFO were selected to represent the lower (PHFO-L) and upper (PHFO-U) range of 22:1 contents, 4.3 and 13.8%, respectively. A third test oil was prepared from a 50:50 blend of these (PHFO-M) to provide and intermediary 22:1 level. The control PHSBO and LEAR contained 0 and 1.0% 22:1, respectively. These experimental oils were included in semi-purified diets at 8 and 16%, respectively, in the breeding and life span periods of the study, together with 4% of oil mixtures providing essential fatty acids (EFA). Specific pathogen free (SPF). Wistar weanling rats, 200 of each sex, provided the subjects for the breeding period. Sufficient numbers of offspring were obtained in suitable condition from each treatment group to allow selection of a total of 555 weanlings for allocation to the five dietary treatments of the life span period of the study. For the life span period of the study, which was terminated after 107 to 110 weeks of treatment, 50 subjects were allocated to each of the PHSBO, PHFO-L and PHFO-U dietary groups, and 50 males to each of the LEAR and PHFO-M groups. The remaining subjects were allocated to sub-groups for sacrifice four days or 26 weeks after introduction of the life span period diets. All life span group subjects were weighed and had their food intakes recorded, and were subjected to clinical examination, routinely. At designated stages, ophthalmoscopic examination of all subjects was carried out, and samples of blood and urine were obtained from sub-groups for laboratory analysis. All decedent and terminated life span group subjects were subjected to post mortem examination, with weighing of 16 organs.(ABSTRACT TRUNCATED AT 400 WORDS)

UI MeSH Term Description Entries
D008136 Longevity The normal length of time of an organism's life. Length of Life,Life Span,Lifespan,Life Spans,Lifespans
D008297 Male Males
D010938 Plant Oils Oils derived from plants or plant products. Oils, Plant,Oils, Vegetable,Plant Oil,Vegetable Oil,Vegetable Oils,Oil, Plant,Oil, Vegetable
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D004883 Erucic Acids cis-13-Docosenoic Acids. 22-Carbon monounsaturated, monocarboxylic acids. Docosenoic Acids,Brassidic Acids,Acids, Brassidic,Acids, Docosenoic,Acids, Erucic
D005229 Fatty Acids, Monounsaturated Fatty acids which are unsaturated in only one position. Monounsaturated Fatty Acid,Acid, Monounsaturated Fatty,Acids, Monounsaturated Fatty,Fatty Acid, Monounsaturated,Monounsaturated Fatty Acids
D005260 Female Females

Related Publications

I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
January 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
March 1996, Arteriosclerosis, thrombosis, and vascular biology,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
December 1974, Lipids,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
May 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
June 1995, Journal of lipid research,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
September 1973, The Journal of nutrition,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
June 1996, European journal of clinical nutrition,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
November 1969, Lipids,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
May 1998, The Journal of nutrition,
I F Duthie, and S M Barlow, and R Ashby, and J M Tesh, and J C Whitney, and A Saunders, and E Chapman, and K R Norum, and H Svaar, and J Opstvedt
March 1983, Lipids,
Copied contents to your clipboard!